Dr. Vishisht Mehta (Medicine) published an invited editorial in CHEST titled, "The Second Multicenter Intrapleural Sepsis Trial Dosing Regimen of Intrapleural Enzyme Therapy Remains the Benchmark in Parapneumonic Effusions and Empyema, Even Without Dwell Time." This editorial provided commentary on the underlying paper analyzing the effects of medication instilled in the pleural space for complication fluid collections.
